/ACBM
ACBM Stock - Acro Biomedical Co., Ltd.
Healthcare|BiotechnologyOTC
$0.00+0.00%
+$0.00 (+0.00%) • Dec 19
67
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.HOLD
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.50
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).70
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.100
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+10.0%upside
Target: $0.00
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for ACBM
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$0.00 – $0.00
TARGET (TP)$0.00
STOP LOSS$0.00
RISK/REWARD1:-1.0
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta0.47
52W High$4.00
52W Low$0.00
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | N/A | N/A | $658,500 | $1.20M | $687,964 |
| Gross Profit | N/A | N/A | $140,500 | $259,500 | $159,404 |
| Gross Margin | N/A | N/A | 21.3% | 21.7% | 23.2% |
| Operating Income | $-37,958 | $-8,804,367 | $-15,869,737 | $-7,693,578 | $-130,463 |
| Net Income | $-42,297 | $-8,807,573 | $-15,871,443 | $-7,702,078 | $-117,453 |
| Net Margin | N/A | N/A | -2410.2% | -643.2% | -17.1% |
| EPS | $-0.00 | $-0.15 | $-0.26 | $-0.14 | $-0.00 |
Company Overview
Acro Biomedical Co., Ltd. engages in developing and marketing of nutritional products. It sells cordycepin and cordyceps powder, a fungus used in traditional Chinese medicine. The company was formerly known as Killer Waves Hawaii, Inc. and changed its name to Acro Biomedical Co., Ltd. in January 2017. Acro Biomedical Co., Ltd. was incorporated in 2014 and is based in Fishers, Indiana.
Visit WebsiteLoading analyst ratings...
Earnings History & Surprises
ACBMBeat Rate
0%
Last 0 quarters
Avg Surprise
+0%
EPS vs Estimate
Beats / Misses
0/0
Last 12 quarters
Latest EPS
$-0.00
Q3 2025
EPS Surprise History
Q3 23
No data
Q3 25
No data
Q3 25
No data
Q3 25
No data
Q3 25
No data
Q3 25
No data
Q3 25
No data
Q3 25
No data
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q3 2025 | Aug 5, 2025 | — | $-0.00 | — | — |
Q3 2025 | Jul 24, 2025 | — | $-0.00 | — | — |
Q3 2025 | Jul 24, 2025 | — | $-0.00 | — | — |
Q3 2025 | Jul 23, 2025 | — | $-0.00 | — | — |
Q3 2025 | Jul 23, 2025 | — | $-0.00 | — | — |
Q3 2025 | Jul 22, 2025 | — | $-0.00 | — | — |
Q3 2025 | Jul 18, 2025 | — | $-0.00 | — | — |
Q1 2024 | Jan 9, 2024 | — | — | — | — |
Q3 2023 | Aug 14, 2023 | — | $-0.05 | — | — |
Q3 2023 | Jul 21, 2023 | — | $-0.07 | — | — |
Q3 2023 | Jul 21, 2023 | — | $-0.07 | — | — |
Q4 2022 | Nov 21, 2022 | — | $-0.07 | — | — |
Q3 2022 | Aug 12, 2022 | — | $-0.07 | — | — |
Q2 2022 | May 16, 2022 | — | $-0.07 | — | — |
Q2 2022 | Apr 15, 2022 | — | $-0.07 | — | — |
Q4 2021 | Nov 22, 2021 | — | $-0.05 | — | — |
Q3 2021 | Aug 23, 2021 | — | $-0.02 | — | — |
Q2 2021 | May 24, 2021 | — | $-0.00 | — | — |
Q2 2021 | Apr 2, 2021 | — | $-0.00 | — | — |
Q4 2020 | Nov 17, 2020 | — | $-0.00 | — | — |
Latest News
Loading news...
Frequently Asked Questions about ACBM
What is ACBM's current stock price?
Acro Biomedical Co., Ltd. (ACBM) is currently trading at $0.00 per share. The stock has moved +0.00% today.
What is the analyst price target for ACBM?
No analyst price targets are currently available for this stock.
What sector is Acro Biomedical Co., Ltd. in?
Acro Biomedical Co., Ltd. operates in the Healthcare sector, specifically within the Biotechnology industry. The company is traded on the OTC exchange.
What is ACBM's market cap?
Acro Biomedical Co., Ltd. has a market capitalization of $0.00 billion, making it a small-cap company.
Does ACBM pay dividends?
No, Acro Biomedical Co., Ltd. does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorAMBS
Amarantus BioScience Holdings, Inc.
$0.00
Mkt Cap: $0.0B
BSSP
Baseline Productions, Inc.
$0.00
Mkt Cap: $0.0B
HDVY
Health Discovery Corporation
$0.00
Mkt Cap: $0.0B
IBXG
iBX Group, Inc.
$0.00
Mkt Cap: $0.0B
IGRW
Interactive Health Network
$0.00
Mkt Cap: $0.0B
ITMC
Itoco Inc.
$0.00
Mkt Cap: $0.0B
MLPH
Molecular Pharmacology (USA), Ltd.
$0.00
Mkt Cap: $0.0B
NSPDF
Naturally Splendid Enterprises Ltd.
$0.04
Mkt Cap: $0.0B
ONBI
ONE Bio Corp.
$0.00
Mkt Cap: $0.0B
RGDXQ
Response Genetics, Inc
$0.00
Mkt Cap: $0.0B
Explore stocks similar to ACBM for comparison